HOME >> BIOLOGY >> NEWS
New science investigations, a fresh team ready for Expedition Three on International Space Station

New science investigations, a fresh ground crew to operate experiments, two more science racks, and delivery of Leonardo -- the logistics module carrying experiments to the International Space Station -- are all contributions of NASA's Marshall Space Flight Center in Huntsville, Ala., to the next Space Station expedition.

The Aug. 9 launch of Space Shuttle Discovery on the STS-105 mission will mark the beginning of the newest four-month science expedition -- Expedition Three -continuing through the landing of the Space Shuttle Endeavor on STS-108 mission in early December.

Discovery will deliver more scientific experiments and a new three-member crew to the Space Station, and return to Earth with scientific equipment, samples and data, as well as the three Expedition Two crew members.

"We will focus more on the research program," said John Uri, lead increment scientist for Expedition Three at NASA's Johnson Space Center in Houston, Texas. "We are on our way to building and maintaining a world-class science research laboratory in low-Earth orbit."

To conduct 18 U.S. experiments during Expedition Three, Uri's team will work closely with the Payload Operations Center - NASA's command post for Space Station science activities at the Marshall Center. A new cadre of controllers replaced their Expedition Two colleagues and started working on Aug. 6 in three shifts, around-the-clock, seven days a week. Their mission is to link Earth-bound researchers with experiments and astronauts aboard the Space Station.

"Science is happening on the station 24-hours a day-- even when the crew is sleeping," said Ray Echols, the lead payload operations director who heads the cadre working in the science control center at Marshall. "Allocation of a small amount of the crew's time to set up and install experiments can yield a lot of science.

Once many experiments are started, we can control them remotely from the ground."Via communications and
'"/>

Contact: Steve Roy
steve.roy@msfc.nasa.gov
256-544-0034
NASA/Marshall Space Flight Center News Center
8-Aug-2001


Page: 1 2 3 4

Related biology news :

1. Student science contest participation influences study, career choices, alumni say
2. Houston minority graduation rises in sciences, engineering as result of UH-led alliance
3. New Arizona State center brings science to policy on issues of water resources and urban growth
4. 4 October press briefing to focus on minority recruitment to science and engineering programs
5. Agronomy, crop, and soil science societies to meet Oct. 31 to Nov. 4 in Seattle
6. News tips from the Journal of Neuroscience
7. Former US Secretary of the Interior Bruce Babbitt to speak at science symposium
8. News tips from the Journal of Neuroscience
9. Discoveries in neuroscience
10. News tips from the Journal of Neuroscience
11. MSU group reviews Berkeley venture into brave new science funding world

Post Your Comments:
(Date:5/24/2013)... noise in one French Quarter neighborhood of New Orleans ... ordinances, Annette Hurley, PhD, Assistant Professor of Audiology at ... a third-year LSUHSC doctor of audiology student, recommend that ... health. Their case study is published online in the ... ., "An important part of an audiologist,s practice is ...
(Date:5/23/2013)... world,s most popular fruit, can be made both better-tasting ... varieties. , "Working with GM tomatoes that are ... a specific compound, allows us to pinpoint exactly how ... from the John Innes Centre. , The research could ... and shelf life characteristics because even higher levels of ...
(Date:5/23/2013)... suppresses lipid synthesis in the liver, UC Irvine endocrinologists ... liver diseases. , With this finding, Dr. Ellis ... in the field. Study results appear in the May ... , "The dogma in the steroid receptor field for ... the nucleus respond to steroid hormones by regulating genes ...
Breaking Biology News(10 mins):Please do try this at home 2The world's favorite fruit only better-tasting and longer-lasting 2UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2
(Date:5/24/2013)... (PRWEB) May 24, 2013 Vestiage, ... lifestyle company focused on science-based research and development, ... anti-aging cosmeceuticals and nutraceuticals, announced today that it ... States for the sale of Reluma Skin Illuminating ... packet and application by sending an email to ...
(Date:5/23/2013)...  BioScrip, Inc. (NASDAQ: BIOS ) today ... 2013 Global Healthcare Conference to be held June 3-6, ... Richard Smith , President and Chief ... Chief Financial Officer, will present on Monday, June 3, ... About BioScrip BioScrip, Inc. provides comprehensive infusion ...
(Date:5/23/2013)... Ind. , May 23, 2013  Rahal Letterman ... in human cord blood stem cell banking and therapeutics, ... of the No. 16 Acorn Stairlifts Indy car driven ... for the remainder of the IZOD IndyCar 2013 season. ... (RLL) will work to support awareness of umbilical cord ...
(Date:5/23/2013)... PARK, Calif. , May 23, 2013 ... oral treatment for pain has reached an important milestone, ... trial of VBY-036 - a selective cathepsin S inhibitor. ... VBY-036 is a double-blind, randomized, placebo-controlled study designed to ... doses of VBY-036 in healthy adults. "The ...
Breaking Biology Technology:Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3
Cached News: